Amid a spate of investments in U.S. pharmaceutical production, two contract manufacturers are joining the fray with separate biologics expansions. More: Veranova, Enzene plot new biologic manufacturing expansions on East Coast Source: fierce
read moreAustin Read of Thermo Fisher Scientific discusses how combining biospecimens with real-world data is advancing diagnostics, treatment and the future of patient care. More: Precision medicine’s next frontier: unlocking the power of biospecimens Source: fierce
read moreRoche and AbbVie have come up short again in their effort to gain an additional indication for their blockbuster blood cancer treatment Venclexta. More: Roche, AbbVie say trial of Venclexta in patients with myelodysplastic syndromes falls short Source: fierce
read more
Collaboration aims to improve rapid detection and personalised treatments More: EDX medical partners with spire healthcare to advance disease diagnostics Source: News
read moreSupernus Pharmaceuticals will snap up Sage Therapeutics, which was once valued at more than $9 billion, for $561 million up front, with the hope that it can help transform a newly launched treatment for postpartum depression into the indication’s standard
read moreWith the move, all of Eli Lilly’s Zepbound doses will soon be available in cheaper single-dose vials for $499 per month or less. More: Eli Lilly adds high-dose Zepbound options to lineup of cheaper vials available on self-pay website Source:
read more© 1994 - 2025 B.M. Pharmaceuticals